Cite
HARVARD Citation
Stein, E. et al. (2016). Long-term treatment with evolocumab homozygous familial hypercholesterolemia patients: Results from the trial assessing long-term use of PCSK9 inhibition in subjects with genetic LDL disorders (Taussig). Atherosclerosis. pp. e44-. [Online].